)
Edge2 May 2025
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
Johnson & Johnson
Johnson & Johnson (JNJ) investor relations material
Johnson & Johnson Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary21 Jan, 2026
Executive summary
Achieved full-year 2025 sales of $94.2B, up 6.0% year-over-year, with operational growth of 5.3% and strong performance across six key business areas: oncology, immunology, neuroscience, cardiovascular, surgery, and vision.
Diluted EPS reached $11.03, up 90.6% year-over-year, including a $7B talc reserve reversal and special charge reversals; adjusted EPS was $10.79, up 8.1%.
Both Innovative Medicine and MedTech segments delivered strong operational growth, driven by new product launches, commercial execution, and major acquisitions (Intra-Cellular Therapies, Halda Therapeutics).
28 platforms/products now generate at least $1B in annual revenue, supporting sustainable growth.
2025 marked by significant R&D and M&A investment ($32B+), new manufacturing facilities, and pivotal product and regulatory milestones.
Financial highlights
Q4 2025 worldwide sales: $24.6B, up 9.1% year-over-year; U.S. sales up 7.5%, international up 11.3%.
Q4 net earnings: $5.1B, up 49.1%; diluted EPS: $2.10, up 48.9%; adjusted net earnings: $6B; adjusted EPS: $2.46, up 20.6%.
Full-year net earnings: $26.8B, up 90.6%; adjusted net earnings: $26.2B, up 8.1%.
Gross margin for 2025 was 67.9%; operating margin at 34.6%.
Free cash flow for 2025 was ~$19.7B, with $20B in cash/marketable securities and $48B in debt at year-end.
Outlook and guidance
2026 operational sales growth expected at 5.7%-6.7% (midpoint $100B); reported sales growth 6.2%-7.2%.
Adjusted operational EPS guidance: $11.28-$11.48 (midpoint 5.5% growth); reported adjusted EPS: $11.53.
Free cash flow expected to rise to ~$21B in 2026.
2026 adjusted pre-tax operating margin to improve by at least 50 bps.
Guidance incorporates 53rd week, MedTech tariffs, U.S. government agreement, and higher share count.
Bridge to double-digit growth by decade end
OTTAVA's unique market position and impact
INLEXZO's market expansion and J-code impact?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- RYM
Refreshed strategy targets NZD 150m cash flow uplift, NZD 500m release, and resumed dividends by FY 2028. - 8002
Profit forecast raised to ¥540.0B and annual dividend to ¥107.50 per share after strong results. - COF
Profit rebounded, NTA and occupancy rose, with strong leasing and premium divestment. - NUF
Statutory loss reported, seeds business repositioned, new CEO appointed, all resolutions passed. - 8303
Profit and comprehensive income surged, with public funds fully repaid and TSE Prime listing completed. - EMR
Q1 2026 saw 4% sales growth, 6% EPS growth, and raised guidance, driven by automation demand. - ENPH
Q4 2025 revenue was $343.3M, down sequentially, with Q1 2026 guidance at $270–$300M. - CMG
2025 revenue up 5.4% to $11.9B, net income $1.54B, with new growth strategy launched. - SMCI
Q2 revenue up 123% year-over-year to $12.7B; FY26 guidance raised to at least $40B. - PNI
Record inflows and global expansion drive growth, with major international acquisitions completed.
Next Johnson & Johnson earnings date
TD Cowen 46th Annual Health Care Conference3 Mar, 2026
Johnson & Johnson
Next Johnson & Johnson earnings date
TD Cowen 46th Annual Health Care Conference3 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Johnson & Johnson, a healthcare conglomerate and manufacturer of consumer products was founded in 1886 by brothers Robert Wood and Johnson Johnson. Today, the company operates in three segments – Consumer Health, Pharmaceutical and Medical Devices. The company sells its products to general public and retail outlets as well as distribute directly to wholesalers, hospitals, healthcare professionals for prescription use.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage